"From surgeries to startups—Apollo’s Q1 results reveal a digital health revolution!"

🏥 Key Financial Highlights - Net Profit: ₹433 crore - Up 42% YoY from ₹305 crore - Up 11% QoQ from ₹390 crore - Revenue: ₹5,842 crore - Up 15% YoY from ₹5,086 crore - Up 4.5% QoQ from ₹5,592 crore - EBITDA: ₹852 crore - Up 26% YoY - Operating margin improved to 14.6% from 13.3% 🚀 Strategic Moves & Expansion - Demerger: Omni Channel Pharmacy & Digital Health into Apollo Healthtech Ltd - Bed Expansion: - 700 beds in Bengaluru (total 1,500) - 4,370 beds planned over 3–4 years - AI Initiatives: - OraLife: Early oral cancer detection - Apollo Zen: Preventive care platform - Digital Platform (Apollo 24/7): - Quarterly GMV: ₹682 crore - Strong demand in teleconsultations & diagnostics 🔬 Segment Performance | Segment | Q1 FY26 Revenue | YoY Growth | | Healthcare Services | ₹2,974 crore | +12% | | Retail Health & Diagnostics | ₹435 crore | +19% | | Digital Health & Pharmacy | ₹2,472 crore | +19% | 🚀 Major Support at Rs. 7000 & 7200 🚀 Major Resistance at Rs. 7500 & 8000